Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 9, Number 9—September 2003

Dispatch

Microbiologic Characteristics, Serologic Responses, and Clinical Manifestations in Severe Acute Respiratory Syndrome, Taiwan1

Po-Ren Hsueh*, Cheng-Hsiang Hsiao*, Shiou-Hwei Yeh†, Wei-Kung Wang*, Pei-Jer Chen*, Jin-Town Wang*, Shan-Chwen Chang*, Chuan-Liang Kao*Comments to Author , Pan-Chyr Yang*Comments to Author , and The SARS Research Group of National Taiwan University College of Medicine and National Taiwan University Hospital2
Author affiliations: *National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan; †National Health Research Institute, Taipei, Taiwan

Main Article

Figure 2

Timelines of positive reverse-transcription polymerase chain reaction, antibody responses and treatment regimens (ribavirin, corticosteroid, and intravenous immunoglobulin) after onset of disease in seven patients with severe acute respiratory syndrome. Panels A–C indicate patients 1, 2, and 4.

Figure 2. Timelines of positive reverse-transcription polymerase chain reaction, antibody responses and treatment regimens (ribavirin, corticosteroid, and intravenous immunoglobulin) after onset of disease in seven patients with severe acute respiratory syndrome. Panels A–C indicate patients 1, 2, and 4.

Main Article

1The first and the second author contributed equally to this paper.

2The SARS Research Group of National Taiwan University College of Medicine and National Taiwan University Hospital includes the following: Ding-Shinn Chen, Yuan-Teh Lee, Che-Ming Teng, Pan-Chyr Yang, Hong-Nerng Ho, Pei-Jer Chen, Ming-Fu Chang, Jin-Town Wang, Shan-Chwen Chang, Chuan-Liang Kao, Wei-Kung Wang, Cheng-Hsiang Hsiao, and Po-Ren Hsueh.

TOP